Development code · Small Molecule
COR588
COR588 is a development code for LHP588, developed by Cortexyme, Inc. (now Quince Therapeutics, Inc.).
- Status
- Phase 2 for Alzheimer's disease
- Mechanism
- Lysine-gingipain (Kgp) Inhibitor
Programs
- LHP588 for Alzheimer's diseasePhase 2Recruiting
Also known as
- LHP588
- LHP-588
- COR-588
- COR588 HCl